Direct Selection of DNA-Encoded Libraries for Biased Agonists of GPCRs on Live Cells

[1]  Casey J. Krusemark,et al.  Selection methods for proximity-dependent enrichment of ligands from DNA-encoded libraries using enzymatic fusion proteins , 2022, Chemical science.

[2]  H. Kolmar,et al.  Engineering of ultraID, a compact and hyperactive enzyme for proximity-dependent biotinylation in living cells , 2022, Communications Biology.

[3]  G. Skiniotis,et al.  Structure‐Based Evolution of G Protein‐Biased μ‐Opioid Receptor Agonists , 2022, bioRxiv.

[4]  Xiaoyu Li,et al.  Strategies for developing DNA-encoded libraries beyond binding assays , 2022, Nature Chemistry.

[5]  Xiaoyu Li,et al.  Evolution of the Selection Methods of DNA-Encoded Chemical Libraries. , 2021, Accounts of chemical research.

[6]  J. Scheuermann,et al.  Affinity selections of DNA-encoded chemical libraries on carbonic anhydrase IX-expressing tumor cells reveal a dependence on ligand valence. , 2021, Chemistry.

[7]  B. Roth,et al.  Biased ligands at opioid receptors: Current status and future directions , 2021, Science Signaling.

[8]  Jing Wang,et al.  Selective Discovery of GPCR Ligands within DNA-Encoded Chemical Libraries Derived from Natural Products: A Case Study on Antagonists of Angiotensin II Type I Receptor. , 2021, Journal of medicinal chemistry.

[9]  A. Satz,et al.  Selections and Screenings of DNA-Encoded Chemical Libraries against Enzyme and Cellular Targets. , 2021, Bioorganic & medicinal chemistry letters.

[10]  Xiaoyu Li,et al.  Selection of DNA-encoded chemical libraries against endogenous membrane proteins on live cells , 2020, Nature Chemistry.

[11]  Samuel A. Myers,et al.  Proximity labeling in mammalian cells with TurboID and split-TurboID , 2020, Nature Protocols.

[12]  A. Strasser,et al.  A Dynamic, Split-Luciferase-Based Mini-G Protein Sensor to Functionally Characterize Ligands at All Four Histamine Receptor Subtypes , 2020, International journal of molecular sciences.

[13]  S. Schulz,et al.  Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor. , 2020, Trends in pharmacological sciences.

[14]  C. Stove,et al.  A novel nanobody-based bio-assay using functional complementation of a split nanoluciferase to monitor Mu- opioid receptor activation , 2020, Analytical and Bioanalytical Chemistry.

[15]  C. Tucker,et al.  Photo-SNAP-tag, a light-regulated chemical labeling system. , 2020, ACS chemical biology.

[16]  Elyssa B. Margolis,et al.  Biased signaling by endogenous opioid peptides , 2020, Proceedings of the National Academy of Sciences.

[17]  J. R. Lane,et al.  Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists , 2020, Science Signaling.

[18]  S. Carr,et al.  Split-TurboID enables contact-dependent proximity labeling in cells , 2020, Proceedings of the National Academy of Sciences.

[19]  Reid H. J. Olsen,et al.  Nanobody-enabled monitoring of kappa opioid receptor states , 2020, Nature Communications.

[20]  S. Schulz,et al.  Morphine‐induced respiratory depression is independent of β‐arrestin2 signalling , 2020, British journal of pharmacology.

[21]  Michael K. Wendt,et al.  Selection of DNA-encoded Libraries to Protein Targets Within and On Living Cells. , 2019, Journal of the American Chemical Society.

[22]  R. V. van Rijn,et al.  A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists , 2019, Front. Pharmacol..

[23]  V. Gurevich,et al.  GPCR Signaling Regulation: The Role of GRKs and Arrestins , 2019, Front. Pharmacol..

[24]  C. Stove,et al.  Activity-Based Concept to Screen Biological Matrices for Opiates and (Synthetic) Opioids. , 2018, Clinical chemistry.

[25]  N. Perrimon,et al.  Efficient proximity labeling in living cells and organisms with TurboID , 2018, Nature Biotechnology.

[26]  Marlene T. Kim,et al.  Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking , 2018, PloS one.

[27]  J. Steyaert,et al.  A Genetically Encoded Biosensor Reveals Location Bias of Opioid Drug Action , 2018, Neuron.

[28]  Ryan T. Strachan,et al.  Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor , 2018, Cell.

[29]  Kyle V. Butler,et al.  Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs , 2017, Nature chemical biology.

[30]  David E. Gloriam,et al.  Trends in GPCR drug discovery: new agents, targets and indications , 2017, Nature Reviews Drug Discovery.

[31]  Arthur Christopoulos,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein‐coupled receptors , 2017, British journal of pharmacology.

[32]  L. Bohn,et al.  Seeking (and Finding) Biased Ligands of the Kappa Opioid Receptor. , 2017, ACS medicinal chemistry letters.

[33]  Ryan T. Strachan,et al.  Allosteric “beta-blocker” isolated from a DNA-encoded small molecule library , 2017, Proceedings of the National Academy of Sciences.

[34]  Henry Lin,et al.  Structure-based discovery of opioid analgesics with reduced side effects , 2016, Nature.

[35]  S. Rasmussen,et al.  Allosteric coupling from G protein to the agonist binding pocket in GPCRs , 2016, Nature.

[36]  L. Bohn,et al.  Biased agonism: An emerging paradigm in GPCR drug discovery. , 2016, Bioorganic & medicinal chemistry letters.

[37]  Jean Zhang,et al.  Cell-Based Selection Expands the Utility of DNA-Encoded Small-Molecule Library Technology to Cell Surface Drug Targets: Identification of Novel Antagonists of the NK3 Tachykinin Receptor. , 2015, ACS combinatorial science.

[38]  R. Lerner,et al.  Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects , 2015, Nature Communications.

[39]  Stephen M. Husbands,et al.  Structural insights into μ-opioid receptor activation , 2015, Nature.

[40]  L. Orzechowski,et al.  DNA Compatible Multistep Synthesis and Applications to DNA Encoded Libraries. , 2015, Bioconjugate chemistry.

[41]  J. Violin,et al.  Structure-activity relationships and discovery of a G protein biased μ opioid receptor ligand, [(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the treatment of acute severe pain. , 2013, Journal of medicinal chemistry.

[42]  Guodong Liu,et al.  A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphine , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[43]  E. Kobatake,et al.  Development of a split SNAP-tag protein complementation assay for visualization of protein-protein interactions in living cells. , 2012, The Analyst.

[44]  J. Javitch,et al.  6′-Guanidinonaltrindole (6′-GNTI) Is a G Protein-biased κ-Opioid Receptor Agonist That Inhibits Arrestin Recruitment* , 2012, The Journal of Biological Chemistry.

[45]  Arthur Christopoulos,et al.  A simple method for quantifying functional selectivity and agonist bias. , 2012, ACS chemical neuroscience.

[46]  M. Bradley,et al.  Decoding a PNA encoded peptide library by PCR: the discovery of new cell surface receptor ligands. , 2011, Chemistry & biology.

[47]  Maria F. Sassano,et al.  Discovery of β-Arrestin–Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy , 2011, Proceedings of the National Academy of Sciences.

[48]  M. Rask-Andersen,et al.  Trends in the exploitation of novel drug targets , 2011, Nature Reviews Drug Discovery.

[49]  M. Bradley,et al.  Encoded peptide libraries and the discovery of new cell binding ligands. , 2011, Chemical communications.

[50]  R. Lefkowitz,et al.  Therapeutic potential of β-arrestin- and G protein-biased agonists. , 2011, Trends in molecular medicine.

[51]  P. Schiller,et al.  Agonist vs antagonist behavior of delta opioid peptides containing novel phenylalanine analogues in place of Tyr(1). , 2009, Journal of medicinal chemistry.

[52]  Marjeta Urh,et al.  HaloTag: a novel protein labeling technology for cell imaging and protein analysis. , 2008, ACS chemical biology.

[53]  S. Salvadori,et al.  Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore. , 2006, Journal of medicinal chemistry.

[54]  D. Shangguan,et al.  Aptamers evolved from live cells as effective molecular probes for cancer study , 2006, Proceedings of the National Academy of Sciences.

[55]  L. Bohn,et al.  Morphine Side Effects in β-Arrestin 2 Knockout Mice , 2005, Journal of Pharmacology and Experimental Therapeutics.

[56]  Corey W. Liu,et al.  Characterization of the FKBP.rapamycin.FRB ternary complex. , 2005, Journal of the American Chemical Society.

[57]  K. Haldar,et al.  A bifunctional molecule that displays context-dependent cellular activity. , 2003, Journal of the American Chemical Society.

[58]  S. Salvadori,et al.  Dmt and opioid peptides: A potent alliance , 2003, Biopolymers.

[59]  H. Vogel,et al.  A general method for the covalent labeling of fusion proteins with small molecules in vivo , 2003, Nature Biotechnology.

[60]  Christine C. Hudson,et al.  The cellular distribution of fluorescently labeled arrestins provides a robust, sensitive, and universal assay for screening G protein-coupled receptors. , 2002, Assay and drug development technologies.

[61]  M. Palmer,et al.  Cell-Based High-Throughput Screening Assay System for Monitoring G Protein-Coupled Receptor Activation Using β-Galactosidase Enzyme Complementation Technology , 2002, Journal of biomolecular screening.

[62]  Marc G. Caron,et al.  μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence , 2000, Nature.

[63]  R. Lefkowitz,et al.  β-Arrestin 2: A Receptor-Regulated MAPK Scaffold for the Activation of JNK3 , 2000 .

[64]  R. Mullins,et al.  β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2 , 2000, The Journal of cell biology.

[65]  J. Arends,et al.  Selection-dominant and nonaccessible epitopes on cell-surface receptors revealed by cell-panning with a large phage antibody library. , 1999, European journal of biochemistry.

[66]  A. Giordani,et al.  (2S)-1-(arylacetyl)-2-(aminomethyl)piperidine derivatives: novel, highly selective kappa opioid analgesics. , 1991, Journal of medicinal chemistry.

[67]  M. Caron,et al.  beta-Arrestin: a protein that regulates beta-adrenergic receptor function. , 1990, Science.

[68]  P. Alcock,et al.  ICI 204448: a κP‐opioid agonist with limited access to the CNS , 1989 .

[69]  J. Black,et al.  Operational models of pharmacological agonism , 1983, Proceedings of the Royal Society of London. Series B. Biological Sciences.